Safety and Efficacy of VDMN-21 Patch in Subjects With Common Warts

NCT05799157 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

153

Enrollment

INDUSTRY

Sponsor class

Conditions

Verruca Vulgaris
Warts
Common Wart

Interventions

DRUG: VDMN-21 Patch Low Dose
DRUG: VDMN-21 Patch High Dose
DRUG: Vehicle Patch

Sponsor

Veradermics, Inc.